1. Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis. Issue 11 (1st October 2016) Authors: Scharbatke, Eva C.; Behrens, Frank; Schmalzing, Marc; Koehm, Michaela; Greger, Gerd; Gnann, Holger; Burkhardt, Harald; Tony, Hans‐Peter Journal: Arthritis care & research Issue: Volume 68:Issue 11(2016:Nov.) Page Start: 1607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab. Issue 19 (May 2020) Authors: Schmalzing, Marc; Behrens, Frank; Schwaneck, Eva C.; Koehm, Michaela; Greger, Gerd; Gnann, Holger; Burkhardt, Harald; Tony, Hans-Peter Other Names: Lai. Jenn-Haung section editor. Journal: Medicine Issue: Volume 99:Issue 19(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial. (January 2023) Authors: Koehm, Michaela; Rossmanith, Tanja; Foldenauer, Ann C; Herrmann, Eva; Brandt-Jürgens, Jan; Burmester, Gerd R; Kellner, Herbert; Kiltz, Uta; Kofler, David M; Rech, Jürgen; Mojtahed-Poor, Sorwe; Jonetzko, Christin; Burkhardt, Harald; Behrens, Frank; Alten, Rieke H.E.; Benesova, Karolina; Bergner, R... Journal: Lancet Issue: Volume 5:Number 1(2023) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab. (13th July 2018) Authors: Behrens, Frank; Koehm, Michaela; Schwaneck, Eva C; Schmalzing, Marc; Gnann, Holger; Greger, Gerd; Tony, Hans-Peter; Burkhardt, Harald Journal: Rheumatology Issue: Volume 57:Number 11(2018) Page Start: 1938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0121 PATIENT CHARACTERISTICS AND INCIDENCE OF SIGNS OF INFLAMMATION IN PATIENTSWITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS AND POSITIVE ANTI-CITRULLINATED PEPTIDE POINT-OF-CARE TEST IN GERMANY – THE PANORA TRIAL. (June 2019) Authors: Koehm, Michaela; Henkemeier, Ulf; Rossmanith, Tanja; Mergenthal, Karola; Petersen, Juliana J.; Burkhardt, Harald; Behrens, Frank Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study). (5th March 2021) Authors: Behrens, Frank; Koehm, Michaela; Rossmanith, Tanja; Alten, Rieke; Aringer, Martin; Backhaus, Marina; Burmester, Gerd R; Feist, Eugen; Herrmann, Eva; Kellner, Herbert; Krueger, Klaus; Lehn, Annette; Müller-Ladner, Ulf; Rubbert-Roth, Andrea; Tony, Hans-Peter; Wassenberg, Siegfried; Burkhardt, Harald Journal: Rheumatology Issue: Volume 60:Number 11(2021) Page Start: 5318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗